Leukemia Research
Volume 29, Issue 7 , Pages 771-783 , July 2005

Establishment and characterization of SRIK-NKL: a novel CD8+ natural killer/T cell line derived from a patient with leukemic phase of acute lymphoblastic lymphoma

  • Bejai I.S. Srivastava

      Affiliations

    • Department of Laboratory Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    • ,
  • Maya D. Srivastava

      Affiliations

    • The Division of Allergy and Immunology, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 216 444 6945; fax: +1 216 445 2104; pager: +1 800 329 3709.

Received 11 July 2004 ,Accepted 17 December 2004.

References 

  1. Greer JP, Kinney MC, Loughran TP. T-cell and NK cell lymphoproliferative disorders. Hematology (Am Soc Hematol Educ Program). 2001;259–281
  2. Mc Queen KL, Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol. 2002;14:615–621
  3. Jones DC, Young NT. Natural killer receptor in transplantation. Eur J Immunogenet. 2003;30:159–176
  4. Young NT, Uhrberg M, Phillips JH, Lanier LL, Parham P. Differential expression of leukocyte receptor complex-encoded Ig-like receptor correlates with the transition form effector to memory CTL. J Immunol. 2001;166:3933–3941
  5. Yawata M, Yawata N, McQueen KL, Cheng NW, Guethlein LA, Rajalingam R, et al. Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics. 2002;54:542–550
  6. Vemeris MR, Karami M, Baker J, Jayaswal A, Negrin RS. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells. Blood. 2004;103:3065–3072
  7. Vitale M, Falco M, Castriconi R, Parolini S, Zambello R, Semenzato G, et al. Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur J Immunol. 2003;31:233–242
  8. Pessino A, Sivori S, Bottino C, Malaspina A, Morellil L, Moretta L, et al. Molecular cloning of NKp46: a novel member of the immunoglobulin super family involved in triggering of natural cytotoxicity. J Exp Med. 1998;188:955–960
  9. Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, Malaspina A, et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin super family. J Exp Med. 1999;189:785–795
  10. Pende D, Parolini S, Pessino A, Sivovi S, Augugliaro R, Morelli L, et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med. 1999;190:1505–1516
  11. Sivori S, Cantoni C, Parolini S, Marcenaro E, Conte R, Moretta L, et al. IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur J Immunol. 2003;33:3439–3447
  12. Ferlazzo G, Thomas D, Lin S, Goodman K, Morandi B, Muller WA, et al. The abundant NK cells in human secondary lymphoid tissue require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol. 2004;172:1455–1462
  13. Jonges LE, Albertsson P, vanVlierberghe RLP, Ensink NG, Johansson BR, vanDevelde CJH, et al. The phenotypic heterogeneity of human natural killer cells: presence of at least 48 different subsets in the peripheral blood. Scand J Immunol. 2001;53:103–110
  14. Koopman LA, Kopcow HD, Rybalow B, Boyson JE, Orange JS, Schatz F, et al. Human decidual national killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med. 2003;198:1201–1212
  15. Leon F, Roldan E, Sanchez L, Camarero C, Bootello A, Roy G. Human small intestinal epithelium contains functional natural killer lymphocytes. Gastroenterology. 2003;125:345–356
  16. Hammond KJL, Godfrey DI. NKT Cells: potential targets for autoimmune disease therapy. Tissue Antigens. 2002;159:353–363
  17. Moretta L, Romagnani C, Pietra G, Moretta A, Mingari MC. NK-CTLS, a novel HLA-E restricted T cell subset. Trends Immunol. 2003;24:136–143
  18. Menier C, Saez B, Horejsi V, Martinozzi S, Krawice-Radanne K, Brael S, et al. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA Class I molecules. Hum Immunol. 2003;64:315–326
  19. Matsuo Y, Drexler HG. Immunoprofiling of cell lines derived from natural killer cell and natural killer-like T-cell leukemia lymphoma. Leuk Res. 2003;27:935–945
  20. Drexler HG, Matsuo Y. Malignant hematopoietic cell lines:in vitro models for the study of natural killer cell leukemia-lymphoma. Leukemia. 2000;14:777–782
  21. Srivastava BIS, Srivastava A, Srivastava MD. Phenotype, genotype and cytokine production in acute leukemia involving progenitors of dendritic langerhan's cell. Leuk Res. 1994;18:499–511
  22. Srivastava MD, Bhargava AK. Expression of dipeptidylammo peptidose-IV in come human T and B cell lines. Acta Haemat. 1986;76:25–28
  23. Kramer MD, Fruth V, Simon HG, Simon MM. Expression of cytoplasmic granules with T cell-associated serine protemase-1 activity in Ly-2+(CD8+) Tlymphocytes responding to lymphocytic choriomeningitis virus in vivo. Eur J Immunol. 1989;19:151–156
  24. Tenner-Racz K, Racz P, Thomas C, Meyer CG, Anderson PJ, Schlossuian SF, et al. Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immuno-deficiency virus-1-infected patients. Am J Pathol. 1993;142:1750–1758
  25. Tsudo M, Kozak RW, Goldman CK, Waldmann TA. Demonstratoin of a non-Tac peptide that binds interleukin 2. A potential participant in a multi-chain interleukin eceptor complex. Proc Natl Acad Sci. 1986;83:9694–9698
  26. Srivastava BIS, Gonzales C, Loftus R, Fitzpatrick JE, Saxinger CW. Examination of HTLV-1 ELISA positive leukemia/lymphoma patients by Western blotting gave mostly negative and undeterminate reaction. AIDS Res Hum Retroviruses. 1990;6:617–627
  27. Uemori T, Asada K, Kato I, Harasawa R. Amplicatication of the 16S–23S spacer region in RRNA operons of mycoplasmas by the polymerase chain reaction. Syst Appl Microbiol. 1992;15:181–186
  28. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, et al. Human diversity in killer cell inhibitory receptor genes. Immunity. 1997;7:753–763
  29. Castriconi R, Cantoni C, Chiesa MD, Vitale M, Marcenaro E, Conte R, et al. Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors. Consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci. 2003;100:4120–4125
  30. Perez SA, Sotiropoulou PA, Gkika DG, Mahaira LG, Nicarchos DK, Gritzapis AS, et al. A novel myeloid like NK cell progenitor in human umbilical cord blood. Blood. 2003;101:3444–3450
  31. Medvedev AE, Johnson AC, Haux J, Steinkger B, Egeberg K, Lynch DH, et al. Regulation of Fas and Fas-ligand expression in NK cells by cytokines and involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity. Cytokines. 1997;9:394–404
  32. Gansuvd B, Hagihara M, Higuchi A, Ueda Y, Tazume K, Tsuchiya T, et al. Umbilical cord blood dendritic cells are a rich source of soluble HLA-DR: synergistic effect of exosomes and dendritic cells on autologous or allogeneic T cell proliferation. Hum Immunol. 2003;64:427–439
  33. Inoue M, Matsuoka M, Yamaguchi K, Takatsuki K, Yoshinda M. Characterization of mRNA expression of IKBα and MF-KB subfamilies in primary adult T-cell leukemia cells. Jpn J Cancer Res. 1998;89:53–59
  34. Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukamaki Y, Niho Y, et al. Expression of DNA methyltransferases DNMT 1, 3A and 3B in moral hematopoiesis and in acute and chronic myelogenos leukemia. Blood. 2001;97:1172–1179
  35. Keates AC, Castagliuolo I, Cruickshank WW, Qui B, Arseneau KO, Brazer W, et al. Interleukin-16 is upregulated in Crohn's disease and participates in TNBS colitis in mice. Gastroenterology. 2000;119:972–982
  36. Marshall JD, Aste-Amezaga M, Chehimi SS, Murphy M, Olsen H, Trinchieri G. Regulation of human IL-18 mRNA expression. Clin Immunol. 1999;90:15–21
  37. Ballerini P, Blaise A, Busson-LeConiat M, Su XY, Zucman-Rossi J, Adam M, et al. A Hox 11 L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood. 2002;100:991–997
  38. Kanai Y, Ushingima S, Dondo Y, Nakanishi Y, Hirshashi S. DNA methyl transferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer. 2001;91:205–212
  39. Kim SV, Flavell RA. CD8αα and T cell memory. Science. 2004;304:529–530
  40. Barao I, Hudig D, Ascensao JL. IL-15 mediated induction of LFA-1 is a late stop required for cytotoxic differentiation of human NK cells from CD34+ Lin− bone marrow cells. J Immunol. 2003;171:683–690
  41. Srivastava MD. The modulation of expression of proinflammatory cytokines in human hematopoietic cells. Ph.D. thesis, SUNY Buffalo 1995.
  42. Srivastava MD, Ambrus JL, Srivastava BIS. Cytokine production by normal and malignant human cell lines. In: 17th International cancer congress—Brazil. Monduzzi Editore, SPA-Bologna, Italy. 1998;p. 115–118
  43. Srivastava MD, Srivastava BIS, Brouhard B. Delta-9-tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology. 1998;40:179–185
  44. Choi SS, Chhabra VS, Nguyen OH, Ank BJ, Stiehm ER, Roberts RR. Interleukin-15 enhances cytotoxicity receptor expression and expansion of neonatal natural killer cells in long-term culture. Clin Diag Lab Immunol. 2004;11:879–888
  45. Yamasaki S, Maeda NM, Ohshimas K, Kikuchi M, Otsuka T, Haradam M. Growth and apoptosis of human natural killer cell neoplasms: role of interleukin-2/15 signalling. Leuk Res. 2004;28:1023–1031
  46. Obata-Onai A, Hashimoto SI, Onai N, Kurachi M, Nagais S, Shizuno KI, et al. Comprehensive gene expression analysis of human NK cells and CD8+ T lymphocytes. Int Immunol. 2002;14:1085–1098
  47. Teng JMC, Liu XR, Mills GB, Dupont B. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidyl inositol 3-kinase and protein kinase C. J Immunol. 1996;156:3222–3232
  48. Gong JH, Maki G, Klingemann HG. Characterization of human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia. 1994;8:652–658
  49. Marcenaro E, Augigliaro R, Faico M, Casticoni R, Parolini S, Sivori S, et al. CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity. Eur J Immunol. 2003;33:3367–3376
  50. Ming Chen I, Whalen M, Bankhurst A, Sever CE, Doshi R, Hardekopf D, et al. A new human natural killer leukemia cell line, IMC-1. A complex chromosomal rearrangement defined by spertral karyotyping: functional and cytogenetic characterization. Leuk Res. 2004;28:275–284
  51. Yagita M, Huang CL, Umehara H, Masuo Y, Tabata R, Mivake M, et al. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia. 2000;14:922–930
  52. O’Connor R, Cesano A, Lange B, Finan J, Nowell C, Clark SC, et al. Growth factor requirements of childhood acute T-lymphoblastic leukemia: correlation between presence of chromosomal abnormalities and ability to grow permanently in vitro. Blood. 1991;77:1534–1545
  53. Maghazachi AA. G protein coupled receptors in natural killer cells. J Leukoc Biol. 2003;74:16–24
  54. Srivastava MD, Srivastava BIS. Expression of mRNA and proteins for Toll-like receptors, associated molecules, defensins and LL-37 by SRIK-NKL, a CD8+ NK/T cell line. Leuk Res. 2004;
  55. Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, et al. Contribution of human α-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science. 2002;298:995–1000
  56. Levy JA. The search for the CD8+ cell anti-HIV factor (CAF). Trends Immunol. 2003;24:628–632

PII: S0145-2126(05)00030-5

doi: 10.1016/j.leukres.2004.12.017

Leukemia Research
Volume 29, Issue 7 , Pages 771-783 , July 2005

Article Tools

* Image Usage & Resolution